Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 2:14:1184612.
doi: 10.3389/fneur.2023.1184612. eCollection 2023.

Case report: Neuronal intranuclear inclusion disease presenting with acute encephalopathy

Affiliations
Case Reports

Case report: Neuronal intranuclear inclusion disease presenting with acute encephalopathy

Julia Ting Bu et al. Front Neurol. .

Abstract

Neuronal intranuclear inclusion disease (NIID), a neurodegenerative disease previously thought to be rare, is increasingly recognized despite heterogeneous clinical presentations. NIID is pathologically characterized by ubiquitin and p-62 positive intranuclear eosinophilic inclusions that affect multiple organ systems, including the brain, skin, and other tissues. Although the diagnosis of NIID is challenging due to phenotypic heterogeneity, a greater understanding of the clinical and imaging presentations can improve accurate and early diagnosis. Here, we present three cases of pathologically proven adult-onset NIID, all presenting with episodes of acute encephalopathy with protracted workups and lengthy time between symptom onset and diagnosis. Case 1 highlights challenges in the diagnosis of NIID when MRI does not reveal classic abnormalities and provides a striking example of hyperperfusion in the setting of acute encephalopathy, as well as unique pathology with neuronal central chromatolysis, which has not been previously described. Case 2 highlights the progression of MRI findings associated with multiple NIID-related encephalopathic episodes over an extended time period, as well as the utility of skin biopsy for antemortem diagnosis.

Keywords: arterial spin labeling; case report; chromatolysis; magnetic resonance imaging; neuronal intranuclear inclusion disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Axial FLAIR (A), T1 post-contrast (B), and ASL (C) demonstrate cortical edema, cortical and pial enhancement, and marked hyperperfusion involving the left temporal and occipital lobes. DWI (D) and ADC (E) show T2 shine-through but no definite restricted diffusion in the involved regions. Also noted is a chronic infarct in the right frontal lobe.
Figure 2
Figure 2
Pathologic features of NIID on biopsies from all three patients: Hematoxylin- and eosin-stained sections [(A–C); 400x magnification] from biopsies on all three patients showed prominent intranuclear eosinophilic inclusions (arrows), seen within neurons also exhibiting central chromatolysis in the brain biopsy from patient 1, the eccrine glandular epithelium on the skin biopsy from patient 2, and neurons and glia on brain biopsy from patient 3. All intranuclear inclusions were immunoreactive for ubiquitin [(D–F); arrowheads]. Electron microscopy on all three specimens confirmed the presence of intranuclear fibrillar inclusions (G–I).
Figure 3
Figure 3
DWI, ADC, and FLAIR from 2017 (A–C), 2019 (D–F), and 2021 (G–I) demonstrate progressive diffusion restriction at the corticomedullary junction of the bilateral frontal and parietal lobes, as well as diffuse confluent white matter FLAIR hyperintensity.
Figure 4
Figure 4
Axial FLAIR (A), T1 post-contrast (B), DWI (C), and ADC (D) demonstrate diffuse cortical edema and patchy cortical enhancement throughout the left cerebral hemisphere on a background of corticomedullary diffusion restriction involving the bilateral frontal and left parietal lobes as well as diffusion restriction in the corpus callosum.

References

    1. Lu X, Hong D. Neuronal intranuclear inclusion disease: Recognition and update. J Neural Transm. (2021) 128:295–303. 10.1007/s00702-021-02313-3 - DOI - PubMed
    1. Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, et al. . Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. (2016) 139:3170–86. 10.1093/brain/aww249 - DOI - PMC - PubMed
    1. Raza HK, Singh S, Rai P, Chansysouphanthong T, Amir A, Cui G, et al. . Recent progress in neuronal intranuclear inclusion disease: A review of the literature. Neurol Sci. (2020) 41:1019–25. 10.1007/s10072-019-04195-6 - DOI - PubMed
    1. Wu C, Wang M, Wang X, Li W, Li S, Chen B, et al. . The genetic and phenotypic spectra of adult genetic leukoencephalopathies in a cohort of 309 patients. Brain. (2022) 2022:awac426. 10.1093/brain/awac426 - DOI - PMC - PubMed
    1. Chen H, Lu L, Wang B, Cui G, Wang X, Wang Y, et al. . Re-defining the clinicopathological spectrum of neuronal intranuclear inclusion disease. Ann Clin Transl Neurol. (2020) 7:1930. 10.1002/acn3.51189 - DOI - PMC - PubMed

Publication types